Skandinaviska Enskilda Banken (SEB)’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-87,500
| Closed | -$1.11M | – | 753 |
|
|
2017
Q2 | $1.11M | Sell |
87,500
-215,800
| -71% | -$2.73M | 0.01% | 598 |
|
|
2017
Q1 | $3.19M | Sell |
303,300
-81,500
| -21% | -$857K | 0.03% | 360 |
|
|
2016
Q4 | $3.54M | Buy |
384,800
+77,100
| +25% | +$709K | 0.04% | 291 |
|
|
2016
Q3 | $3.63M | Sell |
307,700
-26,000
| -8% | -$307K | 0.04% | 318 |
|
|
2016
Q2 | $4.32M | Buy |
333,700
+66,000
| +25% | +$854K | 0.05% | 277 |
|
|
2016
Q1 | $4.28M | Buy |
267,700
+70,200
| +36% | +$1.12M | 0.05% | 273 |
|
|
2015
Q4 | $5.8M | Buy |
+197,500
| New | +$5.8M | 0.08% | 199 |
|